EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Blood pressure lowering effects of β‐blockers as add‐on or combination therapy: A meta‐analysis of randomized controlled trials

Qian-Hui Guo, Zhi-Ming Zhu, Ying-Qing Feng, Jin-Xiu Lin, Ji-Guang Wang

The Journal of Clinical Hypertension · 2023

DOI: 10.1111/jch.14616 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Journal of Clinical Hypertension, 2023. Verfasst von Qian-Hui Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, State Key Laboratory of Medical Geonomics, Shanghai Key Laboratory of Hypertension, Center for Epidemiological…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The authors performed a meta‐analysis to assess the efficacy of non‐atenolol β‐blockers as add‐on to monotherapy or as a component of combination antihypertensive therapy in patients with hypertension. The authors searched and identified relevant randomized controlled trials from PubMed until November 2021. Studies comparing blood pressure lowering effects of β‐blockers with diuretics, calcium channel blockers (CCBs), angiotensin‐converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) were included. The analysis included 20 studies with 5544 participants. β‐blockers add‐on to monotherapy significantly reduced systolic and diastolic blood pressure as compared with non‐β‐blocker monotherapy (weighted mean difference in mm Hg [95% confidence interval]: −4.1 [−6.0, −2.2] and −3.7 [−4.6, −2.8], respectively). These results were consistent across the comparisons with diuretics (systolic pressure, −10.2 [−14.2, −6.2]; diastolic pressure, −5.4 [−8.2, −2.6]), CCBs (systolic pressure, −4.1 [−7.1, −1.0]; diastolic pressure, −2.8 [−4.1, −1.5]), and ACEIs/ARBs (systolic pressure, −2.9 [−4.3, −1.5]; diastolic pressure, −4.2 [−5.0, −3.4]). There was no significant difference in blood pressure lowering effects between combinations with and without a β‐blocker (systolic pressure, −1.3 mm Hg [−5.8, 3.2]; diastolic pressure, −.3 mm Hg [−2.7, 2.1]). Metoprolol add‐on or combination therapy had a significantly greater blood pressure reduction than non‐β‐blocker therapy (systolic pressure, −3.6 mm Hg [−5.9, −1.3]; diastolic pressure, −2.1 mm Hg [−3.5, −.7]). In conclusion, non‐atenolol β‐blockers are effective in lowering blood pressure as add‐on to monotherapy or as a component of combination antihypertensive therapy. In line with the current hypertension guideline recommendations, β‐blockers can and should be used in combination with other antihypertensive drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHumansBlood PressureAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsRandomized Controlled Trials as TopicCalcium Channel BlockersAdrenergic beta-AntagonistsDiuretics

Stichwörter der Autor:innen

beta-blockercombination therapyefficacyhypertensionnon-atenolol

Substanzen

Antihypertensive AgentsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCalcium Channel BlockersAdrenergic beta-AntagonistsDiuretics

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, State Key Laboratory of Medical Geonomics, Shanghai Key Laboratory of Hypertension, Center for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension,…
  • Chongqing Institute of Hypertension, Department of Hypertension and Endocrinology, Daping Hospital, Army Medical University, Chongqing, China.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Cardiovascular Department, The First Affiliated Hospital, Fujian Medical University, Fujian Institute of Hypertension, Fuzhou, China.

Zitieren

APA

Guo, Q. H., Zhu, Z. M., Feng, Y. Q., Lin, J. X., & Wang, J. G. (2023). Blood pressure lowering effects of β‐blockers as add‐on or combination therapy: A meta‐analysis of randomized controlled trials. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14616

Vancouver

Guo QH, Zhu ZM, Feng YQ, Lin JX, Wang JG. Blood pressure lowering effects of β‐blockers as add‐on or combination therapy: A meta‐analysis of randomized controlled trials. The Journal of Clinical Hypertension. 2023. doi:10.1111/jch.14616

BibTeX
@article{Guo2023,
  author = {Guo, Qian-Hui and Zhu, Zhi-Ming and Feng, Ying-Qing and Lin, Jin-Xiu and Wang, Ji-Guang},
  title = {Blood pressure lowering effects of β‐blockers as add‐on or combination therapy: A meta‐analysis of randomized controlled trials},
  journal = {The Journal of Clinical Hypertension},
  year = {2023},
  doi = {10.1111/jch.14616}
}
Kostenlos starten →